Combined low-dose ipilimumab and pembrolizumab after sequential ipilimumab and pembrolizumab failure in advanced melanoma. (Q48582610)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined low-dose ipilimumab and pembrolizumab after sequential ipilimumab and pembrolizumab failure in advanced melanoma. |
scientific article |
Statements
1 reference
Combined low-dose ipilimumab and pembrolizumab after sequential ipilimumab and pembrolizumab failure in advanced melanoma. (English)
1 reference
Axel Hauschild
1 reference
Michael C Kirchberger
1 reference
Gerold Schuler
1 reference
Lucie Heinzerling
1 reference
5 August 2016
1 reference
1 reference
65
1 reference
182-184
1 reference
Identifiers
1 reference
1 reference